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Myoglobin toxicity in proximal human kidney cells: Roles of Fe, Ca2,
H202, and terminal mitochondrial electron transport. The purpose of this
study was to gain direct insights into mechanisms by which myoglobin
induces proximal tubular cell death. To avoid confounding systemic and
hcmodynamic influences, an in Vitro model of myoglobin cytotoxicity was
employed. Human proximal tubular (HK-2) cells were incubated with 10
mg/mI myoglobin, and after 24 hours the lethal cell injury was assessed
(vital dye uptake; LDH release). The roles played by heme oxygenase
(HO), cytochrome p450, free iron, intracellular Ca2, nitric oxide, H202,
hydroxyl radical (0H), and mitochondrial electron transport were as-
sessed. HO inhibition (Sn protoporphyrin) conferred almost complete
protection against myoglobin cytotoxicity (92% vs. 22% cellviability). This
benefit was fully reproduced by iron chelation therapy (deferoxamine).
Conversely, divergent cytochrome p450 inhibitors (cimetidine, amino-
benzotriazole, troleandomycin) were without effect. Catalase induced
dose dependent cytoprotection, virtually complete, at a 5000 U/mI dose.
Conversely, OH scavengers (benzoate, DMTU, mannitol), xanthine oxi-
dase inhibition (oxypurinol), superoxide dismutase, and manipulators of
nitric oxide expression (L-NAME, L-arginine) were without effect. Intra-
cellular (but not extracellular) calcium chelation (BAPTA-AM) caused
--50% reductions in myoglobin-induced cell death. The ability of Ca2
(plus iron) to drive H202 production (phenol red assay) suggests one
potential mechanism. Blockade of site 2 (antimycin) and site 3 (azide), but
not site 1 (rotenone), mitochondrial electron transport significantly re-
duced myoglobin cytotoxicity. Inhibition of Na,K-ATPase driven respira-
tion (ouabain) produced a similar protective effect. We conclude that: (1)
HO-generated iron release initiates myoglobin toxicity in HK-2 cells; (2)
myoglobin, rather than cytochrome p450, appears to be the more likely
source of toxic iron release; (3) H202 generation, perhaps facilitated by
intracellular Ca27iron, appears to play a critical role; and (4) cellular
respiration/terminal mitochondrial electron transport ultimately helps
mediate myoglobin's cytotoxic effect. Formation of poorly characterized
toxic iron/H202-based reactive intermediates at this site seems likely to be
involved.
Rhabdomyolysis-induced acute renal failure (ARF) has been a
subject of extensive laboratory investigation since Bywaters and
Beall's classic descriptions of this syndrome following the London
bombing raids of World War 11 [1]. These investigations have
clearly demonstrated that this form of ARF has a multifactorial
basis. Three major and interactive injury pathways have been
noted [2]. First, renal vasoconstriction, a consequence of intravas-
cular volume depletion and altered expression of vasoactive
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compounds (such as nitric oxide, endothelin, tumor necrosis
factor, adenosine, platelet activating factor [2—8]) markedly re-
duce renal blood flow (RBF). This directly decreases GFR [9] and
it may also produce ischemic tubular damage [10]. Second,
myoglobin precipitation within distal tubules produces cast for-
mation, and possibly, intratubular obstruction [11—13]. Third,
proximal tubular myoglobin uptake via endocytosis permits ex-
pression of its direct cytotoxic effects [14].
Multiple interrelationships between these three injury pathways
exist and serve to amplify the evolving tissue damage [2]. Some
examples include: renal vasoconstriction markedly potentiates
myoglobin's cytotoxic effects [10, 15]; cast formation accentuates
proximal tubular cell heme protein uptake, increasing the poten-
tial for direct cytotoxicity [14]; and if tubular cell death results, the
necrotic debris provides additional substrate for cast formation,
worsening tubular obstruction and filtration failure. The interde-
pendency of these pathways is underscored by the fact that
interference with just one of them (such as attenuation of
vasoconstriction or cast formation) can completely block the
development of ARF [16].
In recent years, most investigations in this area have focused on
defining the mechanisms by which myoglobin exerts its cytotoxic
effect. The approach generally taken has been to administer
pharmacologic agents targeted against a specific injury pathway,
and then assess whether the severity of myoglobinuric ARF has
been affected. These investigations have produced a number of
important insights. In sum, they suggest that much of myoglobin's
cytotoxic effect stems from iron-driven hydroxyl radical (OH)
generation via the Haber Weiss reaction [17, 18]. This conclusion
stems from observations that iron chelator (deferoxamine) or 0H
scavenger therapy (benzoate, dimethylthiourea) mitigates myohe-
moglobinuric ARF [17, 18]. However, given the multifactorial and
interactive nature of in vivo myohemoglobinuric renal injury, as
noted above, it is impossible to know whether these results stem
from direct versus indirect drug effects on the proximal tubular
epithelium. Furthermore, since the glomerular filtration barrier
prevents delivery of large molecular weight probes to the proximal
tubular epithelium (antioxidant enzymes such as catalase), it is
impossible to fully probe injury pathways with in vivo experiments.
Given these limitations, fl vitro studies of myoglobin eytotoxic-
ity are required to further test specific hypotheses. To this end,
our laboratory recently developed an in vitro model for studying
myoglobin cytotoxicity [19, 20]. Rhabdomyolysis was induced in
either rats or mice, and after allowing one to two hours for
proximal tubular myoglobin uptake, proximal tubular segments
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were isolated from the kidneys to allow in vitro study of rapidly
evolving heme protein cytotoxicity. The principal conclusions
from those studies were as follows: (a) iron is a critical determi-
nant of myohemoglobinuric renal injury, as demonstrated by the
fact that DFO confers a cytoprotective effect; (h) lipid peroxida-
tion is driven by mitochondrial free radical generation, since sites
2 and 3 (but not site 1) mitochondrial respiratory chain inhibitors
blocked lipid peroxidation (but not cell death); and (c) lipid
peroxidation and lethal cell injury are not directly linked (since
multiple agents can produce divergent changes in these two
parameters). However, two potential experimental caveats need
to be kept in mind when interpreting these data: first, tubule
extraction produces isolation artifacts; and second, the heme-
induced proximal tubular injury was well advanced at the time the
tubules were studied in the in vitro setting (as evidenced by a rapid
evolution of cell death). Thus, relatively late, rather than early,
injury events were probed with this model system.
The present studies were designed to further explore mecha-
nisms of myoglobin toxicity using a completely cx vivo system. By
so doing, the limitations imposed by both whole animal experi-
ments and isolated tubule systems can be avoided. To this end, we
have recently observed that if myoglobin is added to cultured
human proximal tubular (HK-2) cells in doses associated with in
vivo nephrotoxicity, lethal injury evolves over a 24 hour period
[21]. Thus, this model could complement prior in vivo and in vitro
investigations in two important ways: (1) cell injury can be studied
without confounding systemic, hemodynamic, and intraluminal
events; and (2) delivery of pharmacologic probes can be delivered
directly to the target of interest during the early, rather than the
late injury phase. Using this approach, we have sought to better
define the mechanisms by which myoglobin mediates cytotoxicity.
In particular, the following issues were addressed: What is the
source and nature of cytotoxic iron generated in response to
tubular cell myoglobin loading? Which reactive oxygen metabo-
lites help to mediate iron's cytotoxic effect? What is the functional
impact of cellular/mitochondrial respiration on the evolution of
myoglobin cytotoxicity (that is, does it directly contribute to cell
death)? Finally, does intracellular Ca2 participate in these
injurous events? The results of those studies form the basis of this
report.
Methods
Cell culture conditions
All experiments were performed using HK-2 cells, an immor-
talized proximal tubular cell line derived from a normal adult
human kidney [22J. They were maintained in keratinocyte serum
free medium (K-SFM; Gihco/BRL, Grand Island, NY, USA) to
which was added 2 mti glutamirie, 5 ng/ml epidermal growth
factor, 40 j.g/ml bovine pituitary extract, 25 U/ml penicillin, and
25 jxg/mi sireptomycin. Prior to experimentation, the cells, grown
in T 75 Costar flasks (Costar, Cambridge, MA, USA), were
trypsinized and transferred to 12- or 24-well Costar cluster plates.
After —24 hours of recovery, they were studied, as described
below. Cell viability in each experiment was assessed by determin-
ing the % of cells which maintained vital dye exclusion (8 j.tg/ml
ethidium bromide, counterstained with 2.3 jxg/ml acridine orange,
and India ink added to quench background fluorescence). One
hundred cells in each of two to three fields were examined, and
the mean was taken as the value for a given well. If a given test
agent exerted a significant protective effect, confirmation of that
result was sought by second technique (% lactate dehydrogenase,
LDH, release; discussed below).
Model of myoglobin cytotoxicily
Twenty-four hours after subculturing the HK-2 cells in cluster
plates, they were subjected to a myoglobin challenge (10 mg/mi;
compatible with concentrations observed uring in vivo models of
heme protein induced ARF [21]). A 40 mg/mI stock solution of
horse skeletal muscle myoglobin (Sigma M0630; lot # 55H7015)
was prepared in Hank's balanced salt solution (HBSS; with Ca
and Mg) by sonication, followed by passage through a 0.45 xM low
protein binding filter. Since only metmyoglobin (Fe3) was com-
mercially available, and since only reduced myoglobin (Fe2) was
found to be cytotoxic (pilot data and [23]), 12 m vitamin C (pH'd
to 7.4 with NaOH) was added to the stock solution to effect a
metmyoglobin — myoglobin conversion. After a one hour incu-
bation at room temperature, the myoglobin was added to the
HK-2 cells (final concentration, 10 mg/ml—3 m vitamin C). They
were then incubated under these conditions for 24 hours.
To test the influence of potential injury pathways, cells were
subjected to the myoglobin challenge in the presence or absence
of selected pharmacologic probes (described below). All test
reagents were added simultaneously with the myoglobin chal-
lenge. To prove that these test reagents had no independent effect
on cell viability, they were added to the cells only in the presence
of K-SFM + vitamin C. Cells cultured only in the presence of
K-SFM + vitamin C served as controls. [Note: vitamin C had first
been shown to have no independent effect on cell viability]. Each
pharmacologic agent was tested on  4 wells of cells on  3
different occasions.
Effect of heme o.rygenase generated free iron
Previous in vivo and isolated tubule experiments of heme
protein toxicity have suggested that heme oxygenase (HO), the
enzyme that splits the porphyrin ring releasing free iron, may
either protect against [19, 24] or help mediate heme protein
toxicity [19]. The following experiment sought to clarify HO's
impact using the present cell culture system. HK-2 cells were
subjected to the myoglobin challenge in the absence or presence
of an HO inhibitor (20 or 100 jxM Sri protoporphyrin; Porphyrin
Products, Logan, UT, USA). It had first been demonstrated that
Sn protoporphyrin had no independent effect on cell viability in
the absence of the myoglobin challenge. After completing the
24-hour myoglohin challenge, cell viability was determined by vital
dye exclusion.
If HO affects the expression of myoglobin cytotoxicity by
releasing iron from the porphyrin ring, it should be possible to
reproduce Sn protoporphyrin's effect by iron chelation therapy.
To make this determination, HK-2 cells were challenged with
myoglobin in the presence or absence of deferoxamine (DFO; 2
mM). Twenty-four hours later the vital dye exclusion was deter-
mined.
Influence of cytochrome p450 inhibitors on the expression of
myoglobin cytotoxicily
Recent evidence suggests that cytochrome p450-derived iron is
a potentially critical determinant of hypoxic [25] as well as
myohemoglobinuric renal injury [26]. These conclusions were
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based on observations that cytochrome p450 inhibitors can confer
cytoprotective effects [25, 26]. The goal of this experiment was to
test whether myoglobin-induced cytotoxicity, as expressed in
HK-2 cells, is also cytochrome p450 dependent. HK-2 cells were
incubated with myoglobin either in the absence or presence of one
of three different cytochrome p450 inhibitors: cimetidine (0.1, 0.2,
0.5 mM [25, 261); aminobenzotriazole (10, 25, 50 iM [27, 28]); or
troleandomycin (0.1, 0.25, 0.5 mivi [29, 30]). These treatments!
dosages had first been shown to have no independent effect on
HK-2 viability. Their impact on cell viability was determined 24
hours later by vital dye exclusion.
Impact of antioxidant interventions on the expression of myoglobin
cytotoxicity
The following experiments were designed to identify those
reactive oxygen species which participate in myoglobin's cytotoxic
effect.
(1) Catalase. HK-2 cells were subjected to the myoglobin
challenge in the absence or presence of 100, 1000, or 5000 U!ml of
bovine liver catalase (C40; Sigma Chemicals). Twenty-four hours
later, the percent of vital dye exclusion was determined. As a
control for this experiment, additional cells were exposed to the
myoglobin challenge in the presence of heat inactivated (100°C x
30 mm) catalase to test whether catalase destruction eliminated
the preparation's cytoprotective effect. To further prove the
specificity of the catalase effect, an equivalent amount of protein
to the 5000 U!ml catalase treatment (bovine serum albumin, BSA;
0.2 mg!ml) was added to the myoglobin challenge to assess
whether cytoprotection would result.
(2) •OJ-I scavengers. 0H scavengers have exerted inconstant
cytoprotective effects in in vivo and in isolated tubule models of
heme protein cytotoxicity [16, 18, 19, 31]. To further test 0H's
pathogenetic role in heme protein-induced tubular injury, HK-2
cells were challenged with myoglobin in the presence or absence
of either dimethylthiourea (DMTU; 10, 100, or 1000 jsM) or Na
benzoate (5 mM, 1 mM, 500 jsM). Since mannitol, a membrane
impermeant 0H scavenger, protects against in vivo myohemoglo-
binuric ARF (such as [31]), its influence on myoglobin-induced
HK-2 cell injury was also assessed (5, 10, 20 mM). Each experi-
ment had its own myoglobin-only control group. After 24 hours,
cell viability was assessed. It had first been demonstrated that
none of these agents in the doses employed had an independent
effect on HK-2 viability.
(3) Glutathione. Glutathione (GSH) administration has been
reported to confer striking protection against the glycerol model
of myohemoglohinuric ARF [321. However, GSH has paradoxi-
cally increased lipid peroxidation in isolated proximal tubule
studies of heme protein cytotoxicity [19]. The following experi-
ment sought to clarify GSH's impact on the evolution of myoglo-
bin cytotoxicity. HK-2 cells were subjected to the myoglohin
challenge in the presence or absence of 4 mvi glutathione (which
had no independent effect on HK-2 viability). Twenty-four hours
later, vital dye exclusion was assessed.
(4) Agents directed against superoxide dismutase. The following
experiments assessed whether superoxide generation, such as via
xanthine oxidase activity, is critical to myoglobin-induced cytotox-
icity. HK-2 cells were subjected to the myoglobin challenge under
normal conditions or in the presence of: (1) a xanthine oxidase
inhibitor (oxypurinol, 100, 1000, 5000 U!ml; solubilized in 0.1 N
NaOH [33]); or (2) superoxide dismutase (10, 250, 500 U!ml; from
bovine erythrocytes; S-2515, Sigma). Vital dye exclusion was
determined 24 hours later. These agents had first been demon-
strated to have no independent effect on cell viability.
(5) Nitric oxide (NO) as a potential determinant of myoglobin
toxicity. NO, a nitrogen-based free radical, has been reported to be
a potentially important mediator of acute tubular damage [34].
Furthermore, increments and decrements in NO expression have
been found to protect against and exacerbate in vivo myohemo-
globinuric ARF, respectively [3]. The present experiments as-
sessed whether agents that alter NO expression influence the in
vitro expression of myoglobin cytotoxicity. HK-2 cells were sub-
jected to the myoglobin challenge under normal conditions or in
the presence of either L-NAME (an NO synthase inhibitor) or L
arginine (the NO synthase substrate). Each agent was added in
either 1 or 3 m concentrations (shown to have no independent
effect on HK-2 viability). Cell viability was assessed 24 hours later
by vital dye exclusion.
Cellular respiration as a determinant of myoglobin cytotoxicity
The goal of the following experiment was to assess the impact
mitochondrial respiration/Na,K-ATPase driven respiration on the
evolution of myoglobin cytotoxicity. Suggesting a potential impact
are our prior observations that mitochondrial electron transport is
a critical determinant of lipid peroxidation in heme-loaded iso-
lated tubular segments [20]. HK-2 cells were subjected to the
myoglobin challenge under the following conditions: (1) com-
bined site 1 + site 2 respiratory chain inhibition (rotenone +
antimycin A addition, respectively, 7.5 sM of each); (2) rotenone
alone (7.5 ILM); (3) antimycin alone (7.5 jIM); or (4) 5 m Na
azide, a site 3 respiratory chain inhibitor. In each instance,
co-incubated cells exposed to myoglobin only, or to the mitochon-
drial inhibitors only, served as controls. Cell viability was assessed
24 hours later. [Note, it has previously been determined that
glycolysis is sufficient to maintain normal HK-2 cell ATP concen-
trations under conditions of mitochondrial respiratory chain
inhibition; hence, cell viability is maintained] [35].
Next, the influence of Na,K-ATPase driven respiration was
assessed. HK-2 cells were incubated with myoglobin in the
absence or presence of ouabain (0.1 or 0.5 mM) and cell viability
was determined 24 hours later. These ouahain doses had first been
shown to have no independent effect on HK-2 viability.
One potential mechanism by which alterations in energy pro-
duction!consumption could influence the expression of myoglohin
cytotoxicity would he via decreased endocytic transport. This
could potentially limit cell myoglohin uptake. To test this possi-
bility, the impact of rotenone!antimycin and ouabain therapy on
endocytic transport was assessed by measuring Lucifer yellow
uptake (a fluorescent marker of endocytosis [36, 37]). l-IK-2 cells
(2 x i0 were cultured for 4 hr under control conditions or in the
presence of either 1 mvi ouabain, or antimycin + rotenone (7.5
jIM each). Lucifer yellow was then added (10 mg!ml; Molecular
Probes, Eugene, OR, USA). After completing an additional three
hours incubation, the cells were washed x 4 with 4°C phosphate
buffered saline, they were soluhilized in 0.5 ml of 0.25% Triton
X-100, and the fluorescence intensity of the cell extracts was
determined with a spectrofluorometer (excitation and emission,
430 and 540 nm, respectively). Extracts prepared from cells in the
absence of Lucifer yellow served as a blank.
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Role of Ca2 as a determinant of myoglobin toxicily
The following experiments tested the hypothesis that cellular
Ca2 overload, with secondary activation of phospholipase A2,
calpain, or endonuclease, are important determinants of myoglo-
bin-induced cytotoxicity. Supporting this possibility are previous
observations that Ca2 overload can exacerbate oxidant tissue
damage [38].
(a) Ca2 chelation experiments. HK-2 cells were challenged with
myoglobin in the presence of either EGTA (1 mM; > extracellular
Ca2 concentration of 0.63 mvt in the myoglobin challenge) or in
the presence of an intracellular Ca2 chelator (BAPTA-AM; 20
tiM; Molecular Probes). Separate control groups (myoglobin
alone) were run for each. It had first been determined that these
Ca2 chelators exerted no effect on cell viability in the absence of
the myoglobin challenge.
(b) PLA2 inhibitor experiments. Cells were subjected to the
myoglobin challenge under: (1) control conditions; (2) in the
presence of an intracellular PLA2 inhibitor (50 /LM aristolochic
acid, in DMSO; Biomol, Plymouth, PA, USA) [39, 40]; or (3) in
the presence of a plasma membrane restricted PLA2 inhibitor
(100 jxM dibucaine) [41]. Previous data indicated that these doses
are effective in preventing another model of HK-2 cell injury
(fluoride toxicity), and that neither inhibitor, as employed, had an
independent effect on HK-2 viability [42].
(c) Calpain inhibitor experiments. Recent studies have suggested
that calpain, the dominant intracellular neutral protease, can be
an important determinant of Ca2 initiated toxic and hypoxic cell
death [43, 44]. To assess its potential role in myoglobin toxicity,
HK-2 cells were exposed to the myoglobin challenge under
control conditions or in the presence of one of the following
calpain inhibitors: (1) calpain 1 inhibitor (3.75, 7.5, 15 .tg/ml;
Sigma); (2) E64 (5, 10, 20 j.Lglml; Sigma [44]); or (3) CBZ (0.1, 0.5,
1 mM; Sigma [44]). Each was shown to have no independent effect
on cell viability.
(d) Endonuclease inhibitor experiments. Endonuclease activation
has recently been suggested as a potentially critical mediator of
Ca2/free radical dependent cell death, as evidenced by the ability
of endonuclease inhibitors (Evans blue, aurintricarboxylic acid) to
confer protective effects [45—49], Hence, HK-2 cells were chal-
lenged with myoglobin in the absence or presence of one of these
two endonuclease inhibitors (Evans blue: 2, 5 jLM; aurintricarboxy-
lie acid, 5, 10 /.LM). Pilot data confirmed that neither agent had an
independent effect on HK-2 viability.
Confirmation of cytoprotection by LDH release
HK-2 cells were cultured in 12 or 24 well plates and they were
subjected to the myoglobin challenge either under control condi-
tions or in the presence of those agents previously shown by vital
dye exclusion to confer a cytoprotective effect (2 mrvi DFO, 100
JLM Sn protoporphyrin, 5000 U/mI catalase, 20 xM BAPTA-AM,
7.5 LLM antimycin A, 5 ms'i Na azide, or 0.1 ms ouabain). After 24
hours, % LDH release was determined [23]. The results were
compared to those obtained with myoglobin treatment alone
(each test agent had its own comparative group; N  3 for each).
Assessment of iron and cytosolic Ca2 loading on cell H202
production
The following experiment assessed whether free iron exposure
and/or cytosolic Ca2 loading increases renal tubular H202
generation. To this end, H202 production was gauged by the
phenol red assay [50]. Pilot studies demonstrated that this assay
lacked sufficient sensitivity to detect H202 production by HK-2
cells. Therefore, proximal tubular segments (PTS) were isolated
from normal mouse kidneys [20] and used for this purpose. Each
PTS preparation (N = 9) were divided into five 2.5 ml aliquots
and they were incubated at 37°C under 95% 02/5% CO2 as
follows: (1) control incubation for < two minutes (to establish
baseline values); (2) 30 minute incubations under normal condi-
tions; (3) 30 minute incubations in the presence of 100 .tM FeSO4;
(4) 30 minute incubations in the presence of 35 jiM A23 187 Ca2
ionophore; and (5) 30 minute incubations in the presence of both
FeSO4 and Ca2 ionophore. Phenol red (264 jiM) and horseradish
peroxidase (HRP; 2.2 jiM) were added at the start of each
incubation. After completing the incubations, a sample (150 jil)
was removed to determine % LDH release, and then 100 p.l of
1 N NaOH was added to 2 ml of the remaining aliquots to quench
the phenol red/H202/HRP reaction. The aliquots were centri-
fuged, and the increase in H202-driven oxidation of phenol red
(absorbance at 610 nm) was assessed. H202 concentrations were
calculated from a standard curve constructed by exogenous H202
addition to PTS buffer (0, 10, 20, 30, 40, and 50 jiM H202). Values
were expressed as nmol H202/mg tubule protein. To confirm that
the assay was detecting H202, 5000 U/ml catalase was added to
the tubules during control and Fe504 incubations (to confirm that
reductions in H202 resulted).
Calculations and statistics
All values are presented as means 1 SEM. Comparisons
between groups were performed by either unpaired or paired
Student's t-test, as appropriate. If multiple comparisons were
made, the Bonferroni correction was applied.
Results
Myoglobin-induced cytotoxicily
The myoglobin challenge caused 60% to 85% loss of cell
viability (vital dye uptake) by the completion of the 24-hour
incubation period. In contrast, 5% vital dye uptake was
observed when the cells were cultured only in the presence of
vitamin C. The latter result was the same as that observed with no
additions to the culture medium.
Heme oxygenase, iron, and cytochrome p450: Effects on myoglobin
cytotoxicity
Heme oxygenase (HO) inhibition with Sn protoporphyrin in-
duced dose dependent cytoprotection against myoglobin toxicity.
At the 100 jIM dose, essentially complete protection was observed
(92 2% vital dye exclusion; Fig. IA). The importance of
HO-driven iron release was further suggested by the fact that 2
mM DFO reproduced Sn protoporphyrin's cytoprotective effect
(Fig. 1B). Conversely, cytochrome p450 did not appear to be a
determinant of myoglobin cytotoxicity in HK-2 cells, since none of
the cytochrome p450 inhibitors, at any of the concentrations,
induced any cytoprotective effect (Fig. 2). If anything, a trend
towards a worsening of myoglobin toxicity was apparent with each
agent despite the fact that none had an independent toxic effect
(Fig. 2).
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Impact of antioxidant strategies on myoglobin cytotoxicily
Neither DMTU, benzoate, nor mannitol induced any cytopro-
tection (Fig. 3 A, B). (The benzoate data were comparable to
those obtained with mannitol, and for simplicity's sake, they are
not depicted). Furthermore, neither superoxide dismutase (SOD;
Fig. 3C) nor oxypurinol altered the extent of myoglobin cytotox-
icity (Fig. 3D).
Manipulations designed to alter NO production had no influ-
ence on myoglobin's cytotoxic effect (data not depicted). Vital dye
exclusion following myoglobin addition with either 0, 1, or 3 mrvi
L-NAME were 26 1%, 20 1% and 23 2%, respectively. In
the presence of either 0, 1, or 3 mi L-arginine, 23 1%, 19
1%, and 24 2% vital dye exclusions were observed. These data
seemingly dissociated NO production from myoglobin's cytotoxic
effect.
In contrast to the above, catalase induced profound dose-
dependent cytoprotection, virtually eliminating myoglobin cyto-
toxicity at the 5000 U/ml dosage (91 1% vital dye exclusion; Fig.
4). This protective influence was not a nonspecific consequence of
protein addition (such as competition for myoglobin endocytic
uptake), since the addition of an equivalent amount of bovine
serum albumin (BSA) had no protective effect (with and without
BSA, 20 3% and 25 4% vital dye exclusion, respectively).
Heat inactivation of the catalase completely destroyed its cyto-
protective effect (Fig. 4).
Despite the fact that the above data suggested that H202 is a
critical determinant of myoglobin cytotoxicity, provision of exog-
enous 4 m glutathione worsened the extent of myoglobin-
induced cell death (Fig. 4). This was despite the fact that GSH
exerted no independent cytotoxicity (> 95% vital dye exclusion
without myoglobiri present).
Influence of mitochondrial!Na,K-A TPase driven respiration
As depicted in Figure 5 mitochondrial respiratory blockade
with combined rotenone and antimycin therapy (R + A) signifi-
cantly attenuated the expression of myoglobin cytotoxicity (46
2% vs. 24 1% vital dye exclusion). This protection was due to
site 2, not site I inhibition since antimycin alone, but not rotenone
alone, reproduced this result (Fig. 5). Site 3 respiratory blockade
with Na azide was also protective (Fig. 5), indicating the critical
role played by the terminal respiratory chain in the development
of myoglobin cytotoxicity. Protection with azide was particularly
noteworthy, given the fact that azide inhibits catalase (which
would be expected to worsen myoglobin toxicity). When applied
to HK-2 cells in the absence of myoglobin, neither antimycin,
rotenone, nor azide caused substantial cell death (88 to 98% vital
dye exclusion; due to the fact that glycolysis is sufficient to
maintain HK-2 cell ATP concentrations under conditions of
mitochondrial respiratory blockade [351).
Ouabain also induced dramatic protection against myoglobin
cytotoxicity (72 4% vital dye exclusion at the 0.1 m dosage;
Fig. 6). This further indicates the critical role for cellular/mito-
chondrial respiration in the expression of myoglobin's cytotoxic
effect.
The protection afforded by ouabain and mitochondrial respira-
tory blockade could not simply be ascribed to inhibition of
endocytic transport. This is because these interventions tended to
increase, rather than decrease, Lucifer yellow uptake (28 6%
and 97 12% increments over control values with ouabain and
mitochondrial inhibition, respectively; each P < 0.005).
Influence of Ca2 as a determinant of myoglobin cytotoxicily
As shown in Figure 7, extracellular Ca2 chelation with EGTA
conferred no cyloprotection despite being used in a dose that has
previously been demonstrated to block a known model of Ca2 F
dependent HK-2 cell death [42]. Conversely, intracellular Ca2
chelation with BAPTA-AM eliminated -50% of myoglobin's
cytotoxic effect (Fig. 7). The relative specificity of this result was
indicated by the facts that: (1) in a different model of toxin-
induced HK-2 injury, BAPTA-AM had no protective effect [42];
and (2) BAPTA-AM does not act as an iron chelator [46].
Representative results obtained with inhibitors of Ca2 depen-
dent processes are presented in Figure 8. The data obtained with
differing doses of each were quite similar, and for the sake of
simplicity, results obtained with only one concentration of each
are depicted. Neither of the PLA2 inhibitors (dibucaine, aristolo-
chic acid) conferred a cytoprotective effect despite being used in
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Fig. 1. Heme oxygenase inhibition and iron chelation block myoglobin
cytotoxicily. Cells were incubated with myoglobin in the presence or
absence of 20 or 100 1.LM Sn protoporphyrin (A) or DFO (B). Myoglobin
caused —80% loss of cell viability. Sn protoporphyrin (100 j.M) and DFO
each conferred essentially complete protection against myoglobin-indueed
cell death. 0 is myoglobin without any test agent; % live cells are by vital
dye exclusion. P < 0.00001.
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Fig. 2. Cytochrome p450 inhibitors do not block myoglobin cytotoxiciiy.
Addition of either cimetidine, aminobenzotriazole, or troleandomycin
(each in 3 different doses) failed to reduce the extent of myoglobin-
induced cell death (vital dye uptake). 0 is myoglobin without any test
agent; % live cells are by vital dye exclusion.
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Fig. 3. Hydroxyl radical scavengers, superoxide dismutase, and a xanthine oxidase inhibitor each fail to mitigate myoglobin cytotoxic effect. Membrane
impermeable (mannitol) or permeable (dimethylthiourea, DMTU) OH scavengers failed to confer cytoprotection. (Not depicted are the Na benzoate
data which were essentially identical to the mannitol results). Superoxide dismutase (SOD) and oxypurinol (an irreversible xanthine oxidase inhibitor)
also exerted no protective effect. 0 is myoglobin without any test agent; % live cells are by vital dye exclusion.
Fig. 4. Catalase blocks, and GSH exacerbates,
myoglobin-induced cytotoxicity. A. Increasing
doses of catalase induced increasing
cytoprotection against myoglobin toxicity (vital
dye uptake). At the 5000 U/mt dose, essentially
complete protection was observed. 0 is
myoglobin/no other treatment. B. If the 5000
U/mI catalase dose (Norm, normal) was
applied, marked cytoprotection was, once again,
observed. Heating catalase to 100°C >< 30
minutes completely destroyed this
cytoprotective effect, consistent with protection
being due to catalase, rather than a
contaminant. C. Addition of 4 msi GSH
significantly worsened myoglobin-induced cell
death. Not shown, GSH addition to cells in the
absence of myoglobin induced no cell death (%
live cells are by vital dye exclusion).
doses previously shown to be effective against a Ca2 JPLA2-
dependent model of HK-2 cytotoxicity [42]. Although one pro-
tease inhibitor (CBZ) did confer significant protection, two other
inhibitors (calpain 1 inhibitor; E64) failed to reproduce this result
(suggesting that CBZ's effect was not specifically mediated by
protease inhibition). Finally, neither endonucicase inhibitor
(Evans Blue, EB; aurintricarhoxylic acid, ATC) had a protective
effect; in fact, the latter approximately doubled the extent of
myoglobin-induced cell death despite being used in non overtly
toxic concentrations; 10 fLM results depicted in Fig. 8). Thus,
endonuelease activation does not appear to be a critical determi-
nant of myoglobin's toxic effect on HK-2 cells.
Confirmation of protection by LDH release
If an intervention was found to be protective by vital dye
exclusion, that protection was confirmed by statistically significant
reductions in % LDH release (Fig. 9).
Effects of iron and cytosolic Ca2 loading on tubule 11202
generation
At time zero (baseline), barely detectable H202 was detected in
the PTS suspension (Fig. 10). After completing a 30-minute
control incubation, 5.2 0.8 nmol H202 production/mg protein
was detected (Fig. 10). The addition of FeSO4 and Ca2 iono-
phore each caused significant increments in lI2O2 generation, and
when these two challenges were present together, fully additive
(hut not synergistic) H202 production resulted. The % LDH
release from these challenges were as follows: control conditions,
12 1%; FeSO4 challenge, 12 1%; Ca2 ionophore, 18 2%;
FeSO4 + Ca2 ionophore, 20 3%. Only the combined FeSO4 -F
ionophore challenge caused a statistically significant rise in LDI-I
release (< 0.025).
Pilot data demonstrated that FeSO4 addition to tubule buffer
(that is, without tubules present) caused no lI2O2 generation,
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Fig. 5. Site 2 (antimycin) and site 3 (azide), but
not site I (rotenone) mitochondrial respiratoiy
chain blockade significantly attenuate myoglobin
cytotoxicity. Addition of rotenone + antimycin
A (R + A) approximately doubled the number
of viable cells after completing the myoglobin
challenge (left). This was due to antimycin (A),
not rotenonc (R), since antimycin alone, but
not rotenone alone, induced protection. Na
azide also conferred significant protection
against myoglobin toxicity, further indicating
the importance of the terminal portion of the
mitochondrial electron transport chain to the
mediation of myoglobin cytotoxicity. 0 is
myoglobin with no other treatment; % live cells
are by vital dye exclusion.
porphyrin ring integrity. Alternatively, if iron release from the
porphyrin ring were critical to cytotoxicity, HO inhibition should
confer a protective effect. Previously published studies have left
this issue unresolved. For example, data from Nath et al [24] and
subsequently confirmed in our laboratory [191 indicate that in vivo
HO inhibition with Sn protoporphyrin worsens myohemoglobin-
uric ARF. However, when myoglobin-laden isolated tubules are
exposed to Sn protoporphyrin, a modicum of cytoprotection
results [191. In an attempt to resolve this paradox, we have
exposed HK-2 cells to myoglobin with and without Sn protopor-
phyrin. At a 100 1M concentration, essentially complete cytopro-
tection resulted. Clearly then, HO is essential for the expression
0 0.1 of myoglobin cytotoxicity. Since free iron is directly toxic to
tubular cells [23], and since DFO fully reproduced the benefit of
HO inhibition, it is highly likely that HO exerts its adverse impact
by releasing toxic iron from the porphyrin ring. Only speculation
is possible as to why HO inhibition paradoxically worsens in vivo
myohemoglobinuric ARF. However, potential adverse systemic
effects (such as a worsening of hemodynamics) could override a
benefit expressed directly at the proximal tubular cell level [19].
The next goal of this study was to test whether the cytochrome
p450 system is a second enzymatic determinant of myoglobin
cytotoxicity. In this regard, Paller and Jacob have suggested that
cytochrome p450 can serve as a labile source of intracellular iron,
and that once released, it helps mediate hypoxic tubular cell injury
[25]. Of direct relevance to the current study, Baliga et al recently
reported that cytochrome p450 inhibitors (such as cimetidine) can
mitigate the glycerol model of myohemoglobinuric ARF [26]. This
led these workers to speculate that cytochrome p450, rather than
myoglobin, may be the more important source of toxic iron
release. Given the confounding variables inherent to in vivo
experiments, we explored this hypothesis further by using the
present cell culture system. Despite using three different cyto-
chrome p450 inhibitors, including cimetidine, no cytoprotection
resulted. There are a number of possible explanations for the
seeming discrepancy between these data and those of Baliga et al.
First, it could simply he that there is a down regulation of
cytochrome p450 expression in cultured, compared to in vivo,
tubular cells; if so, then a protective effect with cytochrome p450
inhibitors might only he observed in the in vir'o state. Second,
cytochrome p450 inhibitors might have affected in vivo myohemo-
globinuric ARF [26] via a systemic, hemodynamic, or intraluminal
effect, rather than by altering injury directly at the tubular level.
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indicating that the source of H202 was the tubules. The specificity
of the assay for H2O2 was confirmed by the fact that catalase
addition to the tubules under control conditions and during the
FeSO4 challenge caused approximately 50% reductions in the
detectable H2O2 generation.
Discussion
The multifactorial nature of rhabdomyolysis-associated ARF
complicates dissection of specific mechanisms by which myoglobin
exerts its direct cytotoxic effect. While important clues can be
gained by applying pharmacologic probes to in vivo experiments,
the data obtained must be considered indirect. This is because any
particular agent theoretically can alter tubular damage not by a
primary action, but rather via an additional interposed event (such
as changes in muscle injury, cytokine generation, cast formation,
or intrarenal hemodynamics). Therefore, hypotheses derived from
in vivo studies require confirmation by in vitro testing. The present
study was designed to help achieve this objective.
The first specific goal of this study was to probe the role of heme
oxygenase (HO) in the initiation of myoglobin's cytotoxic effect. If
myoglobin toxicity were dependent on an intact porphyrin ring,
HO inhibition should worsen myoglobin cytotoxicity by preserving
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Fig. 7. Intracellular, but not extracellular, Ca2
chelation lessens myoglobin toxicity. A. Addition
of an extracellular Ca2 chelator, EGTA, had
no impact on the extent of myoglobin-induced
ccli death. B. Conversely, BAPTA-AM, an
intracellular Ca2 chelator, approximately
doubled the number of cells which survived the
myoglobin challenge. 0 is myoglobin/no other
treatment; % live cells are by vital dye
exclusion.
Fig. 8. Inhibitors of (A) PLA2 (B) calpain, and
(C) endonuclease do not block myoglobin
toxicity. To probe potential pathways by which
intracellular Ca2 chelation might confer
protection, the role of Ca2 dependent enzymes
on the expression of myoglobin toxicity was
assessed. Neither of two PLA2 inhibitors (100
/LM dibucaine, dib; 50 tiM aristolochic acid,
arist), conferred protection. Although one
calpain inhibitor (0.5 msi CBZ) was protective,
this effect could not be reproduced by two
other protease inhibitors (7.5 tiM caipain I
inhibitor, CI; or 20 tiM E64). This suggests that
CBZ's effect was probably not specifically
mediated by protease inhibition. Neither of two
endonuclease inhibitors (5 tiM Evans blue, EB;
i0 tiM aurintricarboxylic acid, ATC) conferred
protection; in fact, ATC worsened myoglobin
toxicity without exerting an independent
cytotoxic effect (data not shown). In summary,
these data suggest that PLA2, calpain, and
endonuclease are not critical determinants of
myoglobin-induced HK-2 cell death (% live
cells are by vital dye exclusion).
Third, differing results could be due to the fact that the present
study and Baliga's employed human and rat kidney cells,
respectively. In this regard, marked differences in levels and
isoforms of cytochrome p450 enzymes exist amongst different
animal species. Whatever the exact explanation, one point
seems clear: cytochrome p450 inhibitors do not necessarily
block the expression of heme protein toxicity directly at the
proximal tubular level.
Since a near constant correlate of myohernoglobinuric injury
has been oxidative tissue damage, workers in this area have
attempted to identifr the responsible reactive oxygen metabo-
lite(s). •OH, generated from H202 in the presence of "catalytic"
iron (that is, via the Haher Weiss reaction), has been most widely
implicated. This is because OH scavengers (such as DMTU and
mannitol) and an iron chelator (DFO) have been reported to
mitigate in vivo myohemoglobinuric ARF. However, inconsistent
results have been obtained, possibly because some antioxidants,
such as DMTU, can exert potent systemic effects. That some
critical probes of the Haber Weiss reaction (such as catalase) gain
little tubular access due to minimal glomerular filtration further
complicates exploration of this issue. Hence, we have explored the
impact of specific antioxidant strategies using the present cell
culture system. No evidence for 01-l mediated damage could he
obtained, since neither DMTU, henzoate, nor mannitol conferred
a protective effect. While a negative result with mannitol could
have been predicted because of limited intracellular access,
DMTU and benzoate do penetrate cells, and still no protection
resulted. This negative result, plus the inability of 0U scavengers
to block tubular injury induced by exogenous FeSO4 [231, seem-
ingly dissociate iron-induced tubular injury from 0H production.
Xanthine oxidase-driven superoxide has also been implicated as a
mediator of acute tubular damage [reviewed in 331. However, that
neither oxypurinol nor SOD were protective helps acquit xanthine
oxidase-driven superoxide production as a mediator of myoglobin
toxicity. NO is a third reactive oxygen metabolite that purportedly
causes tubular damage. However, neither NO inhibition (with
L-NAME) nor L-arginine supplementation impacted on the ex-
tent of myoglobin-induced cell death. This suggests that the ability
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Fig. 9. Confirmation of cytoprotection by %
LDH release. Each agent that was found to
protect against myoglobin toxicity, as assessed
by vital dye exclusion, was also shown to be
protective using a second marker of cell
viability (reduction in % LDH release).
Abbreviations are: DFO, 2 m'vi deferoxamine;
Sn proto, 100 JxM Sn protoporphyrin; oua, 0.1
mM ouabain; BAPTA-AM, 20 A, 7.5 /LM
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of these two agents to alter in vivo myohemoglobinuric ARE stems
from NO's hemodynamic actions, rather than from any direct
tubular cell effect [3].
In striking contrast to the above, catalase was able to com-
pletely block myoglohin's cytotoxicity. To our knowledge, this is
the first demonstration of this action, and it strongly suggests that
H202 is a critical determinant myoglobin-initiated cell death. One
potential mechanism by which H207 could induce lethal injury
would be by fueling OH production via the Haber Weiss reaction.
However, as discussed above, this seems unlikely. A more likely
mechanism may be that H202, which liberates iron from heme
proteins (such as in [511), acts in concert with HO to produce
critical free iron overload, and hence, direct iron-mediated toxic-
ity [23]. Finally, since H202 and free iron can interact to form
highly toxic, but poorly defined, reactive intermediates (other than
•OH [52]), a direct H202-iron derived moiety might mediate
tubular cell death. Unfortunately, specific probes to explore this
possibility do not currently exist.
Given the apparent critical role of H202 in mediating myoglo-
bin cytotoxicity, it may seem paradoxical that supplemental GSH
therapy increased the extent of myoglobin-induced cell death
(Fig. 4). This is particularly true since it has been convincingly
demonstrated that systemic GSH administration can attenuate in
vivo myohemoglobinuric ARF [32]. However, it is important to
recognize that GSH, can exert pro- as well as anti-oxidant effects.
For example, we have previously noted that GSH can worsen lipid
peroxidation in heme loaded isolated tubular segments [19]. In
part, this is because its constituent amino acid cysteine generates
H202 in the presence of catalytic iron [53, 54]. Thus, a failure of
GSH to confer protection against myoglobin toxicity should not
be taken as evidence against H202 as an important determinant of
heme toxicity. Rather, it may actually support this hypothesis [54].
It has previously been reported that increased H202 generation
occurs during the course of the glycerol model of myohemoglo-
binuric ARF [55]. However, the reason for this has remained
unknown. To this end, we tested the hypothesis that free iron
such as liberated by HO, directly stimulates H202 production. To
address this possibility, FeSO4 was added to isolated proximal
tubules and increased tubule H202 generation resulted, as as-
sessed over a 30 minute period. Since intracellular Ca2 loading
was also identified as a critical modulator of myoglobin toxicity
(BAPTA-mediated protection), the impact of cell Ca2 loading
on H202 production was also assessed. Shortly after A23187
ionophore addition, increased H202 resulted. Given the diverse
effects of cell Ca2 loading on cell homeostasis, it is impossible to
directly link this increased H202 production to Ca2' mediated
toxicity. However, no evidence was obtained to support other
Ca24 dependent processes (PLA2, calpain, endonuclease activa-
tion) as being involved. Thus, Ca2 driven H202/free radical
generation remains a tenable hypothesis.
In a recent study, we demonstrated that the terminal portion of
the mitochondrial electron transport system is a critical source of
reactive oxygen metabolites during the course of myohemoglohin-
uria [20]. This conclusion was based on observations that addition
of site 2 or site 3, but not site 1, mitochondrial respiratory chain
inhibitors to heme laden isolated tubules (obtained from myohe-
moglobinuric mice) completely blocked in vitro malondialdehyde
formation. However, the functional significance of this blockade
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Fig. 10. Free iron and cell Ca2 loading each stimulate renal tubular H202
production. Normal mouse proximal tubular segments were subjected to
sublethal FeSO4 (Fe; 100 xM) and Ca2 ionophore (Cal; 35 xM A23 187)
challenges and H202 production was assessed by the phenol red technique
at baseline and over the course of a 30-minute incubation period. In all
instances, H202 production was observed (rise over baseline values), and
the increment was significantly higher in the presence of Fe and Cal (*P <
0.05). The FeSO4 and ionophore-induced increments were fully additive
(Fe + Cal).
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(that is, would it attenuate lethal cell injury?) could not be
assessed. This was because mitochondrial inhibition in isolated
tubules, and the resulting ATP depletion, rapidly induced cell
death. Since HK-2 cells are not dependent on mitochondrial
respiration to maintain ATP levels, and hence cell viability (that
is, glycolysis is sufficient), they provided a unique opportunity to
directly assess the contribution of mitochondrial electron trans-
port to the evolution of myoglobin cytotoxicity. As depicted in
Figure 8, addition of site 2 or site 3, but not site 1, respiratory
chain inhibitors significantly attenuated myoglobin's cytotoxic
effect. Therefore, it is clear that the terminal mitochondrial
respiratory chain is not just a determinant of lipid peroxidation
[201, it is also a critical mediator of myoglobin-induced cell death.
To our knowledge, this is the first evidence that indicates this
mechanistic relationship.
To further pursue the theory that cellular respiration is a key
determinant of myoglobin toxicity, the impact of a more physio-
logically relevant manipulation of cell respiration was assessed:
Na,K-ATPase activity. As shown in Figure 10, when ouabain was
added to HK-2 cells, dramatic cytoprotection resulted. Of note,
neither mitochondrial respiratory chain inhibition nor ouabain
seemingly suppressed endocytic transport, as assessed by the
Lucifer yellow technique. Hence, decreased myoglobin uptake
appears to be an unlikely explanation for the protection observed
with these agents. Thus, the available data strongly suggest that
cellular respiration, in general, and terminal mitochondrial elec-
tron transport, in particular, are key determinants of myoglobin's
cytotoxic effect. The reason for this cannot be stated. However, it
appears likely that decreased formation of putative cytotoxic
H2O2/Fe based reactive intermediates [52] at the site of terminal
electron transfer to molecular oxygen is responsible. It is note-
worthy that Brezis et a! have done much to advance the theory
that cellular metabolic work (Na transport) is a critical determi-
nant of toxic and hypoxic medullary thick ascending limb tubular
cell death [561. They have related much of its impact to ATP
consumption and hence, energy availability. The present study
indicates that: (a) transport activity can also alter the expression
of proximal, and not just distal, tubule injury; and (b) reductions
in oxidant stress and not just energy availability may be involved.
Obviously, cell culture studies have their limitations, making
extrapolation of the present data to previously obtained in vivo
results a subject of potential controversy. Furthermore, since
conclusions drawn from the present study were based on results
obtained using chemical inhibitors/stimulators of biologic pro-
cesses, and since such probes could exert nonspecific effects,
potentially misleading data could have been obtained. Indeed, the
latter consideration is why a major effort was made in this study to
use different types of inhibitors and in multiple doses wherever
possible. Finally, it remains possible that results obtained with
HK-2 cells might not be directly applicable to data obtained by
others using other models of heme protein toxicity. Nevertheless,
that many striking similarities exist between our current results
and those that we have obtained previously with whole animal and
isolated tubule experiments (for example, DFO, Sn protoporphy-
rin mediated protection [19]; decreased oxidant injury with site
2/3 respiratory chain inhibitors [20]; worsened oxidant stress with
GSH [191; and negative results with 0H scavengers [14, 16])
implies that the present results may, in fact, have relevance.
In conclusion, the present study provides the following poten-
tial new insights into the subcellular determinants of myoglobin
cytotoxicity, as assessed with a cultured human proximal tubular
cell system. (1) HO is a critical determinant of myoglobin-induced
injury, as evidenced by the fact that HO inhibition blocks myo-
globin's cytotoxic effect. (2) HO presumably mediates this injury
via free iron release, since iron chelation therapy and HO
inhibition induced comparable degrees of cytoprotection. (3)
myoglobin, rather than cytochrome p450, appears to be a more
likely source of the toxic iron, since agents that reportedly stabilize
labile cytochrome p450 iron exerted no protective effect. (4)
Catalase confers almost total protection against myoglobin cyto-
toxicity, implicating H2O2 as a critical determinant of myoglobin-
initiated cell death. That •OH scavengers were not protective
suggests that non-0H, H2O2 catalyzed, reactive iron intermedi-
ates are involved. (5) Once released, free iron (as well as
intracellular Ca2), can mechanistically contribute to H2O2 gen-
eration. Since H202 liberates iron from porphyrin rings, this can
serve as a positive feedback loop, perpetuating iron-mediated
toxicity. (6) Terminal mitochondrial electron transport appears to
be a critical site of cytotoxic free radical generation during
myoglobin-induced HK-2 cell attack. Presumably, iron-based/
H2O2-driven reactive intermediate formation at that site is in-
volved.
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